These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9061881)

  • 21. Selection of monoclonal antibodies that bind and inhibit tissue-type plasminogen activator.
    Ball EL; Dunlop K; Matsueda GR
    Hybridoma; 1993 Jun; 12(3):317-26. PubMed ID: 8359825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artificial exon shuffling between tissue-type plasminogen activator (t-PA) and urokinase (u-PA): a comparative study on the fibrinolytic properties of t-PA/u-PA hybrid proteins.
    de Vries C; Veerman H; Blasi F; Pannekoek H
    Biochemistry; 1988 Apr; 27(7):2565-72. PubMed ID: 3132969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin oligosaccharides enhance tissue-type plasminogen activator: a correlation between oligosaccharide length and stimulation of plasminogen activation.
    Edelberg JM; Conrad HE; Pizzo SV
    Biochemistry; 1991 Nov; 30(45):10999-1003. PubMed ID: 1932024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The plasminogen activation system in bovine milk: differential localization of tissue-type plasminogen activator and urokinase in milk fractions is caused by binding to casein and urokinase receptor.
    Heegaard CW; Rasmussen LK; Andreasen PA
    Biochim Biophys Acta; 1994 May; 1222(1):45-55. PubMed ID: 8186264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of intact fibrin and partially plasmin-degraded fibrin on kinetic properties of one-chain tissue-type plasminogen activator.
    Fischer BE; Will H
    Biochim Biophys Acta; 1990 Oct; 1041(1):48-54. PubMed ID: 2145980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction and expression of a hybrid plasminogen activator gene with sequences from non-protease region of tissue-type plasminogen activator (t-PA) and protease region of urokinase (u-PA).
    Kalyan NK; Lee SG; Cheng SM; Hartzell R; Urbano C; Hung PP
    Gene; 1988 Sep; 68(2):205-12. PubMed ID: 3146528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of tissue-type plasminogen activator (t-PA) activity by purified t-PA receptor expressed in human endothelial cells.
    Fukao H; Ueshima S; Takaishi T; Okada K; Matsuo O
    Biochim Biophys Acta; 1997 Mar; 1356(1):111-20. PubMed ID: 9099997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poly-lysines as modifiers of one- and two-chain tissue-type plasminogen activator activity.
    Green GD
    Thromb Res; 1986 Dec; 44(6):849-57. PubMed ID: 3099422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the murine plasma fibrinolytic system.
    Lijnen HR; van Hoef B; Beelen V; Collen D
    Eur J Biochem; 1994 Sep; 224(3):863-71. PubMed ID: 7523120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-function analysis with tissue-type plasminogen activator. Effect of deletion of NH2-terminal domains on its biochemical and biological properties.
    Kalyan NK; Lee SG; Wilhelm J; Fu KP; Hum WT; Rappaport R; Hartzell RW; Urbano C; Hung PP
    J Biol Chem; 1988 Mar; 263(8):3971-8. PubMed ID: 3126183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of synergism between tissue-type plasminogen activator and urokinase on plasminogen activation rate in plasma.
    Rydzewski A; Takada Y; Takada A
    Thromb Res; 1989 Mar; 53(6):577-83. PubMed ID: 2499946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the plasminogen activator activity units of urinary-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA).
    Creighton-Kempsford LJ; Pring JB; Gaffney PJ
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):481-3. PubMed ID: 1420825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myosin as cofactor and substrate in fibrinolysis.
    Machovich R; Ajtai K; Kolev K; Owen WG
    FEBS Lett; 1997 Apr; 407(1):93-6. PubMed ID: 9141488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinolytic activity and localization of plasminogen activator in bovine vitreous body and aqueous humor.
    Hayashi K; Nakashima Y; Sueishi K; Tanaka K
    Jpn J Ophthalmol; 1989; 33(1):66-75. PubMed ID: 2499726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma fibronectin enhances fibrinolytic system in vitro.
    Gilboa N; Kaplan JE
    Thromb Haemost; 1985 Oct; 54(3):639-44. PubMed ID: 2935966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of tissue plasminogen activator-catalyzed plasminogen activation by synthetic peptides derived from the amino-terminal heparin binding domain of fibronectin.
    Stack MS; Pizzo SV
    J Biol Chem; 1993 Sep; 268(25):18924-8. PubMed ID: 8360182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of the one-chain to two-chain conversion in tissue plasminogen activator: characterization of mutations at position 275.
    Higgins DL; Lamb MC; Young SL; Powers DB; Anderson S
    Thromb Res; 1990 Feb; 57(4):527-39. PubMed ID: 2139248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of mastitis on plasminogen activator activity of milk somatic cells.
    Zachos T; Politis I; Gorewit RC; Barbano DM
    J Dairy Res; 1992 Nov; 59(4):461-7. PubMed ID: 1452831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
    Sitter T; Toet K; Quax P; Kooistra T
    Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of cell-associated plasminogen activation by stromelysin-1 (MMP-3).
    Ugwu F; Lemmens G; Collen D; Lijnen HR
    Thromb Haemost; 1999 Sep; 82(3):1127-31. PubMed ID: 10494776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.